Articles
| Open Access |
DOI: Correction Of Cognitive Disorder In Patients With HIV - Associated Encephalopathy
Zokirov M.M., , Ferghana Branch Of Tashkent Medical Academy, Uzbekistan Madjidova Y.N. , Taskent Pediatric Medical Institute, UzbekistanAbstract
HIV infection is one of the most pressing medical and social problems in the whole world.
This article discusses one of the varieties of the complication of HIV infection such as HIV
associated encephalopathy. Clinical features and diagnostic criteria for the disease are
considered. Patients were examined using the Montreal cognitive function assessment
scale and symptomatic treatment with the nootropic drug choline alfoscerat
Keywords
HIV infection, human immunodeficiency virus
References
Bartt RE " The Neurology of AIDS " JAMA 2006. P. 295 - 331
Evtushenko SK, Derevyanko I.N. “Actual issues of diagnosis and treatment of
primary and secondary neurospeed ” VESTNIK of the Clinical Hospital No. 51 2009,
pp. 17 - 23
Makarov A.Yu., Chikova RS, Ulyukin I.M., Pomnikov V.G. " Neurological syndromes
in HIV infection . " Neurological Journal 2004; 5: 45-52.
Donovan Maust , Mario Cristancho , Laurie Gray, Susan Rushing, Chris Tjoa .
Chapter 13 - Psychiatric rating scales // Handbook of Clinical Neurology / Michael J.
Aminoff , François Boller , Dick F. Swaab . - Elsevier, 2012-01-01. - T . 106 . - With
. 227–237 .
Ziad S. Nasreddine , Natalie A. Phillips, Valérie Bédirian , Simon Charbonneau, Victor
Whitehead. " The Montreal Cognitive Assessment, MoCA : A Brief Screening Tool For
Mild Cognitive Impairment " Journal of the American Geriatrics Society. - 2005. -
Vol. 53 , iss . 4 . - P. 695-699 .
N.V. Shakhparonova , A. S. Kadykov " The use of choline alfoscerate in patients
with post-stroke cognitive impairment " Difficult patient No. 1 Volume 9 : 2011 p.
-30
Parnetti L., Amenta F., Gallai V. Choline alphoscerate in cognitive decline and in
acute cerebrovascular disease: an analysis of published clinical data. Mech Ageing
Dev 2001;122: 2041 —55.
Article Statistics
Copyright License
Copyright (c) 2020 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.